Methylphenidate Effect on Humphrey Visual Fields

• Status: Completed
• Trial end date: 2018-04-10
• Target enrollment: 0
• Participant gender: All

Summary

Study will include adults with abnormal visual fields. Half of them will be given either methylphenidate 10mg 2 hours before repeating the visual field test. the rest will serve as controls. All Subjects will also have a complete eye examination, a short questionnaire and a questionnaire to screen for attention deficit disorder. The investigators will compare the visual field results between the 2 tests.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• abnormal visual fields

• must be able to swallow pills

Exclusion Criteria:

• psychiatric disorder

• dementia

• ocular disorder which is known to cause abnormal visual fields

• prescription of psychoactive medications

• visual acuity lower than 20/100

• cardiac arrhythmia

• hypersensitivity to methylphenidate

• prescription of warfarin